Ibrushil 140mg Capsule
Prescription Required
Product introduction
Ibrushil 140mg Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy.
It is an anti-cancer medicine.
It is an anti-cancer medicine.
Uses of Ibrushil Capsule
Side effects of Ibrushil Capsule
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youโre worried about them
Common side effects of Ibrushil
- Headache
- Fever
- Diarrhea
- Stomatitis (Inflammation of the mouth)
- Nausea
- Low blood platelets
- Decreased white blood cell count (neutrophils)
- Fatigue
- Musculoskeletal (bone, muscle or joint) pain
- Rash
- Anemia (low number of red blood cells)
- Bruising
- Muscle spasm
- Hemorrhage
- Pneumonia
- Cough
- Dry eye
- High blood pressure
- Weight loss
- Urinary tract infection
- Peripheral edema
- Subdural hematoma
- Second primary malignancies
How to use Ibrushil Capsule
Take this medicine in the dose and duration as advised by your doctor. Ibrushil 140mg Capsule may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Ibrushil 140mg Capsule. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Ibrushil 140mg Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
CAUTION
Ibrushil 140mg Capsule should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving
UNSAFE
Ibrushil 140mg Capsule may cause side effects which could affect your ability to drive.
Kidney
CAUTION
Ibrushil 140mg Capsule should be used with caution in patients with kidney disease. Dose adjustment of Ibrushil 140mg Capsule may be needed. Please consult your doctor.
Liver
CAUTION
Ibrushil 140mg Capsule should be used with caution in patients with liver disease. Dose adjustment of Ibrushil 140mg Capsule may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Ibrushil 140mg Capsule
โน299.7/Capsule
Ibronza 140mg Capsule
Sun Pharmaceutical Industries Ltd
โน257.97/capsule
14% cheaper
โน3270/capsule
991% costlier
IB-Tib Capsule
Cadila Pharmaceuticals Ltd
โน263.3/capsule
12% cheaper
Nitib 140mg Capsule
Hetero Healthcare Limited
โน323.33/capsule
8% costlier
โน3280/capsule
994% costlier
Quick tips
- Take it at the same time every day, either with or without food.
- It is advisable to stay hydrated and drink plenty of fluids while taking this medication.
- Do not skip any dose and complete the course as suggested by your doctor.
- Use an effective method of birth control to avoid pregnancy while taking this medication.
- Your doctor may get regular blood tests done to monitor your liver function and blood cell count in your blood.
Fact Box
Chemical Class
Diphenylethers Derivative
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Bruton's tyrosine kinase (BTK) inhibitors
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:
- Ibrutinib. Beerse Belgium: Janssen Pharmaceutica NV; [Accessed on 27 Mar. 2019] (online) Available from:
Marketer details
Name: Shilpa Medicare Ltd
Address: 12-6-214/A1, Hyderabad Road, Raichur โ 584 135, Karnataka, India.
Country of origin: India
Lab tests offered by us
Related/Popular tests
128 people viewed this recentlyMRP
โน8991
Inclusive of all taxes
30.0 capsules in 1 bottle
SOLD OUT
Variants (2)